Navigation Links
ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - 'NASDAQ, here we come!'
Date:4/7/2008

CHARLES TOWN, W.Va., April 7, 2008 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), President/CEO, David B. Phillips, Ph.D, today announced that the corporation is ready to grow into one of the larger, more efficient, and transparent public equity markets.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

"We have been a publicly held company for a year and have experienced the limitations of being listed only on the Pink Sheets with a large number of shares and a low price per share" said Dr. Phillips. "We have maintained a fully reporting status on Pink Sheets, and are prepared to meet the requirements that the NASDAQ and other markets require. Recent publicity surrounding these small equity markets indicates that without changing the percentage of ownership for our shareholders, we can add value by ensuring our price per share is in line with the larger markets. We do not anticipate offering any new equities, nor do we anticipate using any debt instruments. We are comfortable being a cash company with no receivables and no debt."

"Our next focus will be to evaluate the equity structure of our company to enable us to reach bigger equity markets that can better reflect our credibility. We are reviewing the relevant data and will keep our current investors apprised of our progress," states Dr. Phillips.

For more information visit: http://www.rebuildermedical.com and http://www.molluscum.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.


'/>"/>
SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Reports 1st Quarter 2008 Sales Increase of Over 88%
2. ReBuilder Medical Technologies, Inc. Announces Top Sales Month - $410,000
3. ReBuilder Medical Technologies, Inc. Announces Best Sales Day in 5 Years
4. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
5. ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006
6. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
7. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
8. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
9. ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October
10. ReBuilder Medical Technologies, Inc. Announces Record Sales Month
11. ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 29, 2017 , ... ... leading thyroid pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched ... besides answering common questions regarding thyroid function. , Dr. Izabella Wentz is ...
(Date:3/28/2017)... , ... March 28, 2017 ... ... non-profit medical society dedicated to advancing the science and clinical practice of ... its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul ... , WHAT: , Medical doctors and PhD scientists will speak to the press on ... Trump in support of an independent vaccine safety commission. , WHERE: , Zenger ...
(Date:3/28/2017)... ORANGE, Calif. (PRWEB) , ... March 28, 2017 ... ... of its leading physicians, Paul Yost, will begin serving as new board chair ... earlier this month. Yost will serve the remainder of soon-to-be former chair Mark ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process ... in power plant water and steam. , Chlorides and sulfates cause pitting and ... to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today ... Christopher Gabrieli , partner emeritus ... of the board of Akcea Therapeutics. ... Sandford D. Smith , founder and ... are excited to announce this expansion to our board and ...
(Date:3/28/2017)... 2017 The global surgical ... value of USD 4.5 billion by 2025, according to ... closure of injured tissues post operation is a major ... occur in 3% to 15% of cases and are ... one third of postoperative deaths in patients. Surgical sealants ...
(Date:3/27/2017)... -- The National University of Singapore (NUS) and ... signed a Memorandum of Understanding (MOU) recently to ... region. Under this MOU, the ... (BIGHEART) at NUS and Holmusk will establish a ... IT and medical device development. These include personal ...
Breaking Medicine Technology: